The rising interest in GLP-1 medications for diabetes has led to a debate about delivery methods : skin-applied devices versus pills . Typically, GLP-1 therapies were exclusively available in tablet form, but the development of patches offers a new option . Patches might suit individuals experiencing issues swallowing tablets , those wanting to avo